8-K

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) October 1, 2009

IMS HEALTH INCORPORATED

(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other
Jurisdiction of
Incorporation) No. 001-14049
(Commission
File Number) No. 06-1506026
(IRS Employer
Identification No.)

901 Main Avenue Norwalk, Connecticut	06851
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (203) 845-5200

Former name or former address, if changed since last report: N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 1, 2009, IMS Health Incorporated (the “Company”) announced that its Board of Directors has appointed Gilles V.J. Pajot as Vice Chairman of the Company, a new executive position, effective immediately.  Previously, Mr. Pajot served as the Company’s Executive Vice President and Chief Operating Officer. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit is furnished as part of this report:

Exhibit Number	Description
99.1	Press Release dated October 1, 2009

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		IMS HEALTH INCORPORATED
		(Registrant)
		By:	/s/ Harvey A. Ashman
			Name:  Harvey A. Ashman
			Title:   Senior Vice President, General
			Counsel and External Affairs
Date:	October 1, 2009

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press Release dated October 1, 2009

EX-99.1

Exhibit 99.1

IMS Appoints Gilles Pajot Vice Chairman

NORWALK, Conn.--(BUSINESS WIRE)--October 1, 2009--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that Gilles V.J. Pajot has been appointed vice chairman, a new position. Previously, Pajot was the company’s chief operating officer. He continues to report to David R. Carlucci, IMS chairman and CEO, and is based at the company’s Connecticut headquarters.

In his new role, Pajot, 60, is responsible for extending IMS’s worldwide growth strategy across a broader range of health industry sectors. He will advance the execution of the company’s strategic priorities to create new value for clients and shareholders, while continuing to focus on IMS’s high-growth markets in Asia Pacific and Japan.

With Pajot’s appointment, the company’s Consulting and Services business and regional operations in the Americas and Europe, Middle East and Africa will report to Carlucci.

“Since joining IMS more than a dozen years ago, Gilles Pajot has demonstrated exceptional leadership in building demand for our offerings and strengthening our position in global markets,” said Carlucci. “The breadth of his knowledge and experience, particularly with an expanding set of clients, contributes greatly to our capabilities, and I know that he will take the execution of our strategic vision to a new level. I look forward to his deeper contributions as we build an even stronger foundation for sustained, profitable growth.”

Pajot has 35 years’ experience in the healthcare and pharmaceutical industries and has served in a number of senior-level regional and global roles. While at IMS, he has held executive positions with responsibility for IMS operations in Europe, Middle East and Africa, and global business management. Pajot has been instrumental in enhancing IMS’s value proposition to clients and ensuring strong alignment across the company’s business lines and consulting and services activities worldwide.

About IMS

Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.

CONTACT:
IMS Health
Gary Gatyas, 610-834-5338
ggatyas@us.imshealth.com